The Company

ALGAE DYNAMICS CORP (OTCQB: ADYNF) (the "Company"), is currently engaged in the development of unique health products and pharmaceuticals that utilize hemp, cannabis and algae oils. This is an extension of our plan to commercialize our proprietary BioSilo(R) algae cultivation system for the high volume, low cost production of pure contaminant-free algae biomass which is high in Omega-3 fatty acids. We have engaged two Canadian universities to provide research into the use of extracts from cannabis oil, which we plan to use to develop products that combine the significant health benefits of Omega-3s derived from algae oil and extracts from cannabis oil. Our research is focusing on the use of cannabis oil in the context of cancer, and the use of cannabis derivatives for the development of novel pharmacotherapies for mental health.

Program with the University of Waterloo to perform research and product development on cannabis oil and its constituents in the context of the development and treatment of cancers of the colorectum, pancreas, breast and prostate.

Program with Western University to perform research and product development on cannabis oil and its constituents in the context of depression, post-traumatic stress disorder, anxiety and schizophrenia.

Algae Dynamics' Vision: Our Vision is to be a global leader in the formulation and development of health products from Cannabis derivatives, algae oils, and other botanical oils for health and wellbeing.